Results are available in about 20 minutes via a mobile phone app, and the test is more than 90% accurate in both symptomatic and asymptomatic individuals, the agency announced Tuesday.
Vaccinated long-term care residents in the clear from COVID-19 — for now
By
Danielle Brown
Jul 12, 2021
Long-term care residents and staff fully vaccinated against COVID-19 don’t need booster shots anytime soon, according to federal health officials.
FDA may grant Pfizer vaccine full approval by Labor Day: report
By
Alicia Lasek
Aug 05, 2021
The nationwide rise in COVID-19 cases driven by the highly transmissible delta strain has spurred the agency move quickly, sources told The New York Times.
Clinical Briefs for Wednesday, Nov. 6
By
Alicia Lasek
Nov 05, 2019
Single odds-defying case may lead to new Alzheimer’s treatments … Fully digital Alzheimer’s study to track risk factors in 400,000 volunteers … Blood samples may identify those at risk for frailty...
Clinical briefs for Friday, Oct. 23
By
Alicia Lasek
Oct 23, 2020
Remdesivir becomes first fully FDA-approved COVID-19 treatment in U.S. … Soy consumption may decrease key risk factor for dementia … COVID mortality rate widening between U.S. and peer countries …...
COVID shot boosters for all adults will help to reduce confusion, FDA says
By
Alicia Lasek
Nov 22, 2021
The FDA “heard loud and clear” that a simpler booster strategy was needed, its vaccine chief says. But the action may be too late to head off a winter virus surge, observers say.
FDA accelerates timetable for full approval of Pfizer vaccine
By
Danielle Brown
Aug 05, 2021
It may soon be “go” time for providers that have thus far held off on mandating COVID-19 vaccines for staff members, basing their decisions on the fact vaccines have been approved by the Food and...
Painkiller distribution could be curtailed
By
James M. Berklan
Mar 02, 2013
An advisory panel has recommended making it more difficult for long-term care residents and others to receive certain painkillers. Providers criticize the proposal, saying it could leave seniors suffering...
Promising antidepressant fails in late-stage trial
By
Alicia Lasek
Dec 05, 2019
Fast-tracked antidepressant Sage-217 failed to outperform a placebo in a stage 3 trial, according to its developer.
FDA halts use of REGEN-COV, Eli Lilly monoclonal antibodies
By
Alicia Lasek
Jan 26, 2022
The Food and Drug Administration has revoked its emergency use authorizations for two monoclonal antibody cocktails that have served as COVID-19 treatment mainstays in long-term care facilities.